Edition:
United Kingdom

Adaptimmune Therapeutics PLC (ADAP.O)

ADAP.O on Nasdaq

3.50USD
18 Jun 2019
Change (% chg)

$-0.16 (-4.37%)
Prev Close
$3.66
Open
$3.69
Day's High
$3.78
Day's Low
$3.48
Volume
312,528
Avg. Vol
305,890
52-wk High
$14.54
52-wk Low
$3.20

About

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. The Company has developed a platform that enables it to identify cancer targets, find and genetically engineer TCR,... (more)

Overall

Beta: --
Market Cap(Mil.): $763.12
Shares Outstanding(Mil.): 93.52
Dividend: --
Yield (%): --

Financials

  ADAP.O Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -1.00 -- --
ROI: -32.06 8.90 13.82
ROE: -35.60 10.04 15.24

Earnings vs. Estimates